Clinical Trial Update: Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Tacrosolv for allergic conjunctivitis and allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Tacrosolv

Snippet

Sponsor: Marinomed Biotech AG | Conditions: Allergic Conjunctivitis, Allergic Rhinitis | Phase 2 | Status: COMPLETED